A randomized controlled trial on Aspirin and complex regional pain syndrome after radius fractures by Eraghi, A.S. et al.
Complex regional pain syndrome 
Eur J Transl Myol 30 (1): 202-209, 2020 
- 202 - 
 
A randomized controlled trial on Aspirin and complex regional pain 
syndrome after radius fractures 
Amir Sobhani Eraghi (1), Amir Khazanchin (2), Nima Hosseinzadeh (1,2), Alireza 
Pahlevansabagh (1) 
(1) Department of Orthopaedics Surgery, Rasoul Akram Hospital, Iran University of Medical 
Sciences, Tehran, Iran; (2). Bone and Joint Reconstruction Research Center, Shafa Orthopedic 
Hospital, Iran University of Medical Sciences, Tehran, Iran 
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (CC BY-NC 4.0) which permits 
any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. 
Abstract 
Complex regional pain syndrome (CRPS) is often diagnosed in patients who are recovered with 
surgery or injury. CRPS is usually diagnosed in patients recovering from distal radius fractures. 
The aim of study was the effects of aspirin in prevention of the complex regional pain syndrome 
(CRPS) following a fracture of distal radius. In a double-blind, randomized controlled trial, 91 
patients with unilateral extra-articular distal radius fractures were randomly allocated to receive 
either placebo (PLA) or 500 mg of aspirin (ASA) daily for 7 days. The effect of aspirin on the 
occurrence of CRPS was evaluated. The patients were assessed clinically and radiographically 
in the second, fourth and twelfth weeks by a physician who was unaware of the treatment 
allocation. Ninety-one patients (ASA, n=44; PLA, n=47) were enrolled in the study. The 
prevalence of CRPS in all patients was 16.5%. The prevalence of CRPS in the aspirin group was 
lower (13.6%) than the placebo group (19.1%), but this difference was not statistically 
significant. The only significant difference was the lower rate of regional osteoporosis seen in 
the radiographs of aspirin group. Mean age was significantly higher in the patients with CRPS. 
Also, comminuted distal radius fractures (A3-type) were significantly more common in the 
patients with CRPS. Administration of aspirin in patients with a distal radius fracture was 
associated with a lower incidence of CRPS, but, not statistically significant. Further 
investigations needs to be done with a larger sample size, longer follow-up period and multi-
center design. 
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Sympathetic Dystrophy. 
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 Distal radius fractures are the most common fractures 
that orthopedic surgeons face in their traumatic patients. 
They are responsible for up to 18% of all fractures in the 
elderly population. Most patients heal uneventfully, but 
up to 37% of these fractures may complicate with a 
chronic neurological condition called Complex Regional 
Pain Syndrome (CRPS).1,2 CRPS, also known as Reflex 
Sympathetic Dystrophy (RSD), is characterized by 
severe pain along with sensory, autonomic, motor and 
trophic impairment - ranging from mild and self-limiting 
to chronic disease-3 resulting in dysfunction and 
disability to do daily living activities.4 The pain 
experienced is proportional to the extent of tissue damage 
and is beyond the normal expected time for tissue repair. 
The pathophysiology is multifactorial and involves pain 
regulation in both the sympathetic and central nervous 
systems, with likely genetic, inflammatory and 
psychological contributions.5 There are several theories 
for its pathophysiology, including an exaggerated 
inflammatory response to a trauma, altered sympathetic 
nervous system function, catecholamines, autoimmunity, 
genetic and psychological factors.4 Moreover, there is a 
plethora of medications used to prevent or treat CRPS, 
mostly because of the poorly understood 
pathophysiology.6 
It has been hypothesized that the exaggerated 
inflammatory response to a trauma has an important role 
in the pathophysiology of CRPS. Clinical presentation of 
the acute phase of CRPS, i.e., the affected limb reveals 
pain, edema, erythema, increased temperature and 
impaired function, supports this hypothesis.4,7 
Nonsteroidal anti-inflammatory drugs (NSAIDs), used to 
treat the inflammatory symptoms of CRPS and to relief 
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pain, act by inhibiting cyclooxygenase and preventing the 
synthesis of prostaglandins, which mediate inflammation 
and hyperalgesia. Studies have demonstrated the role of 
spinal cyclooxygenase and its effect on hyperalgesia and 
allodynia.8-11 However, there is a renewed interest in 
studying NSAIDs.  
Aspirin, also known as acetylsalicylic acid (ASA), is a 
medication used to treat pain, fever, or inflammation. The 
anti-inflammatory effects of ASA are mediated by the 
inhibition of cyclooxygenase enzymes. Aspirin works by 
blocking the production of prostaglandins, the on-off 
switch in cells that regulate pain and inflammation, 
among other things. That’s why aspirin stops mild 
inflammation and pain.12,13 Given the multifactorial 
nature and complex pathophysiology of CRPS, the 
number of Randomized Controlled Trials (RCTs) 
assessing the efficacy of pharmacologic agents for its 
prevention and treatment are few, small in scale, non-
controlled, or reported in poster form at meetings.10  
In this RCT study we aimed to evaluate the effects of 
aspirin in prevention of the CRPS following a fracture of 
distal radius. 
Materials and Methods 
Study design 
This double-blind, randomized controlled trial was 
conducted from August 2016 to September 2017, at 
Rasoul Akram Hospital, in Tehran, Iran. The authors 
adhered to the Consolidated Standards of Reporting 
Trials (CONSORT) guidelines. 
Level of Evidence: Level I, Therapeutic study, 
randomized controlled trial (RCT). 
Patient selection 
The method of sampling was census, in such a way that 
patients referred or presented to the emergency 
department of the hospital, with an acute distal radius 
fracture, were entered into the study during 24 months. 
Inclusion criteria includes all patients with eighteen years 
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old and over with a closed, unilateral, extra-articular 
distal radius fracture. Exclusion criteria were a history of 
taking medications for CRPS treatment (antidepressants, 
anticonvulsants, corticosteroids and vitamin C); previous 
wrist or hand fracture on the same side; articular 
displacement requiring open reduction; open fractures; 
neurovascular injury; fractures with high energy 
mechanism, multiple trauma-injured patients; multiple 
fractures at different places; and contraindication to take 
aspirin and acetaminophen. From a total of 261 patients, 
179 were studied and all fractures were assessed 
individually. Eventually, due to some data loss and 
patients being excluded from the study, 91patients were 
evaluated (Figure 1).  
Study protocol  
The protocol was initiated in the emergency department 
after the enrolled persons signed an informed consent. 
Patients were randomly allocated to receive a box with 7 
capsules of either 500 mg aspirin or placebo which 
should be taken one capsule daily. All boxes and capsules 
had been made by a pharmacist with the same appearance 
and taste. Randomization was performed by a pharmacist 
using a table of random numbers. The study was double-
blind and all participants and physicians were unaware of 
the treatment allocation and the pharmacist was the only 
person accessing to the codes until the end of the trial. All 
patients in the study received 1gr intravenous of Apotel 
every 6 hours at the hospital and one tablet of 
acetaminophen 500 mg every 6 hours for a week for pain 
management. 
Surgical technique 
Bier’s block anesthesia was done for all patients. 
Reduction was applied by the “Agee maneuver” with 
traction and flexion. Then, percutaneous pinning was 
performed with two pins from radial styloid and, in some 
patients, an extra pin from the dorsal ulnar aspect of the 
radius to the volar aspect, for further stability of the 
reduction. After the surgery, long arm cast was applied 
for all patients. Four weeks after the surgery, cast was 
changed to the below elbow cast and at the sixth week, 
cast and pins were removed. 
Follow-up 
Demographic characteristics, including age, gender, side 
of the fracture, hand dominance, and fracture type 
(according to the AO/OTA classification) were recorded 
at the time of presentation to the emergency department 
(Table 1). Other information about the symptoms and 
signs of the CRPS and radiographic evaluation were 
recorded during the follow-up period. To improve patient 
adherence, a follow-up phone call was made on the fourth 
or fifth day of the prescription course. The patients were 
assessed clinically and radiographically in the second 
week, the fourth week (the cast was shortened), the sixth 
week (pins and cast were removed) and the twelfth week 
by a physician who was unaware of the treatment 
allocation. Radiographic evaluation including standard 
postero-anterior and lateral radiographs of the injured 
wrist as well as one set of radiographs of the contralateral 
wrist, for comparison, was performed at each visit. 






Age (Mean±SD) 50.86±13.54 52.40±14.55 0.603 
Gender Male 25 (57%) 33 (70%) 0.184 
Female 19 (43%) 14 (30%) 
Hand dominance Left 5 (11%) 9 (20%) 0.304 
Right 39 (89%) 38 (80%) 
Fracture side Left 24 (55%) 21 (45%) 0.347 
Right 20 (45%) 26 (55%) 
Fracture type A2 23 (52%) 25 (53%) 0.93 
A3 21 (48%) 22 (47%) 
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Radiographic findings including patchy, subchondral, or 
subperiosteal osteoporosis were diagnosed by a 
radiologist. The follow-up period ended in December 
2017. CRPS was clinically assessed with the use of the 
“Budapest criteria”, which has an acceptable sensitivity 
and specificity.3,14,15 If the diagnosis of CRPS was made, 
the patient was treated by reassurance, analgesia, and 
careful physical therapy avoiding exacerbation of pain. 
Ethical consideration  
Ethical considerations were observed in this study with 
ethics code of IR.IUMS.FMD.REC 1396.9311242007 
and registered in Iranian Registry of Clinical Trials as: 
(IRCT20180116038391N1) bestowed by Committee of 
Ethics in Medical Research at Iran University of Medical 
Sciences. The qualified persons were identified for 
participation, informed written consent was obtained 
from each participant, the research goals and procedures 
were explained, principles of information confidentiality 
and anonymity were observed, and finally, the 
participants could leave the study at any stage. 
A written Informed consent was obtained from all 
patients contributed in the study. 
Statistical analysis 
 Analysis was performed using SPSS ver.18 (SPSS Inc., 
Chicago, USA). Main null hypothesis: there were no 
significant differences in the incidence of CRPS between 
the aspirin group and placebo group. For analysis of the 
difference between groups, χ2-test and independent-
samples t-test were used to compare proportions and 
continuous variables, respectively. A p-value <0.05 was 
considered statistically significant. 
Results 
During a 14-month period, a total number of 103 patients 
with unilateral, extra- articular distal radius fractures 
participated in the study. Fifty-one patients were 
randomized to receive aspirin, and fifty-two received 
placebo. Twelve patients did not complete the follow-up 
period (one patient was expired because of 
cerebrovascular accident, 6 patients were from other 










Sensory 6 (40%) 5 (11%) 4 (9%) 0.734 
vasomotor 10 (67%) 7 (16%) 9 (19%) 0.685 
Sudomotor/edema 15 (100%) 18 (41%) 15 (32%) 0.372 
Motor/trophic 15 (100%) 17 (39%) 19 (40%) 0.862 
Signs 
Sensory 10 (67%) 7 (16%) 9 (19%) 0.685 
vasomotor 5 (33%) 6 (14%) 9 (19%) 0.479 
Sudomotor/edema 7 (47%) 14 (32%) 13 (28%) 0.664 
Motor/trophic 10 (67%) 13 (29%) 13 (28%) 0.842 
CRPS 6 (13.6%) 9 (19.1%) 0.479 
Time of diagnosis (CRPS)    
4 weeks 1 (17%) 2 (22%) 1.00 
6 weeks 5 (83%) 7 (78%) 
Radiographic changes 7 (16%) 16 (34%) 0.047 
 
Complex regional pain syndrome 
Eur J Transl Myol 30 (1): 202-209, 2020 
- 206 - 
 
states and 5 patients did not continue follow-up after 
removing cast and pins at the sixth week). In total, 91 
patients remained for final assessment that forty-four of 
them received aspirin (as aspirin group), and 47 received 
placebo (placebo group). 
There were no significant differences between two 
groups in terms of demographic characteristics including 
age, gender, hand dominance, fracture side and fracture 
type (Table1). 
The prevalence of CRPS in all patients was 16.5% (15 
patients out of 91 patients). Although, analysis of the two 
groups showed that the prevalence of CRPS in the aspirin 
group was lower (13.6%, 6 of 44 patients) than the 
placebo group (19.1%, 9 of 47 patients), this difference 
was not statistically significant (p = 0.479). Information 
about the prevalence of the symptoms and signs in the 
patients with CRPS and patients who received aspirin or 
placebo are shown in Table 2.The only significant 
difference was the lower rate of regional osteoporosis 
seen in the radiographs of the aspirin group (P=0.047), 
suggesting a significant relationship between the use of 
aspirin and the reduction of radiographic evidence for 
osteoporosis. All fractures healed successfully after 12 
weeks. In most patients, CRPS was diagnosed at 6 weeks 
after the fracture and diagnosis time was not significantly 
different between the two groups. 
There was no difference regarding to the gender between 
the patients with or without CRPS. Mean age was 
significantly higher in patients with CRPS (P=0.008). 
Also, comminuted distal radius fractures (A3-type) were 
significantly more common in the patients with CRPS (P 
= 0.027). Data are shown in Table 3.  
Only 7 patients had pin tract infections (4 form aspirin 
group and 3 from placebo group, P=0.708), which all of 
them were grade I and II and treated without 
complications.  
Discussion 
The complex regional pain syndrome is a nonspecific 
condition with variable symptoms and uncertain values.16 
It was usually diagnosed in the recovery period after 
distal radius fracture.17 While acute CRPS sometimes 
improves spontaneously or with aggressive physical 
therapy, CRPS present for a period of one year or greater 
seldom spontaneously resolves 33, and worsens in many 
patients from years 1 to 8 after onset.18 
This study demonstrated that administration of aspirin in 
the patients with a distal radius fracture was associated 
with a lower frequency of CRPS compared with placebo 
group, but the difference was not statistically significant. 
Furthermore, no significant difference was found 
between the two groups in demographic data, fracture 
specifications and CRPS. The only significant difference 
was the lower rate of regional osteoporosis seen in the 
radiographs of the aspirin group. Moreover, CRPS was 
significantly more frequent in older patients and those 
with comminuted fractures. 
The overall incidence of CRPS in the present study was 
13.6% in aspirin group and 19.1% in the placebo group. 
In the study of Zollinger et al.19 and the studies of Atkins 
et al.20, CRPS incidence in the placebo group was higher 
(22%, 25% and 37%, respectively). This difference might 
be due to the different criteria of our study. We diagnosed 
CRPS based on the “Budapest criteria”, but in the 
mentioned studies, different criteria have been used. 
Additionally, our study included only those patients who 
had an extra-articular fracture which was treated with 
percutaneous pinning. 
Mean age was significantly higher in our patients with 
CRPS. This finding is consistent with those of Demir et 
al.21 and Roh et al.22 Although Ortiz-Romero et al.23 
found that patients under 60 years of age have an elevated 
risk of developing CRPS that might be due to high-
energy fractures in these group of patients 
Demir et al. and Roh et al. showed that female gender has 
been considered a risk factor for CRPS.21, 2,24 Also, 
Young-Hoon Jo et al. stated that risk factors that were 
significantly associated with CRPS-1 incidence included 
female gender, open reduction and open fracture.25 In 
Chung et al. study,26 sex hormones, such as estrogens, are 







Age (Mean±SD) 60.27±9.35 49.96±14.19 0.008 
Gender Male 8 (53%) 50 (66%) 0.359 
Female 7 (47%) 26 (34%) 
Fracture type A2 4 (27%) 44 (58%) 0.027 
A3 11 (73%) 32 (42%) 
 
Complex regional pain syndrome 
Eur J Transl Myol 30 (1): 202-209, 2020 
- 207 - 
 
of more interest with regard to CRPS, due to its high 
incidence in women and at postmenopausal age. 
However, we found no significant sex difference between 
the patients with or without CRPS. 
Our findings showed that comminuted distal radius 
fractures were significantly more common in patients 
with CRPS. This finding could be attributed to more 
inflammation and injury to the bone and surrounding 
tissues due to transferring a higher energy to them. This 
relationship also has been found in other studies.22,27,28 
According to a study by Goh  et al, after a distal radius 
fracture, radiographic features of bone loss and 
demineralization could be seen, either as a result of 
disuse or CRPS progression, leading to nociceptive bone 
pain, osteopenia and osteoporosis.4 Interestingly, based 
on the study of  Chung et al.,  osteoporosis has been 
considered a consequence of CRPS rather than a risk 
factor.26 Other results of cellular and animal studies 
demonstrated that aspirin possesses bone protective 
effects by promoting the survival of osteoblast precursor 
stem cells and differentiation of osteoblast,29-32  but there 
are studies with opposit results.33-35 The 
pharmacodynamics behavior of aspirin in the treatment 
of fracture or the prevention of CRPS is not fully 
understood and there is still controversy due to 
inconclusive data and lack of evidence. Nevertheless, our 
study demonstrated that regional osteoporosis in plan 
radiographs in aspirin group was significantly lower than 
the other group. 
Administration of aspirin in patients with a distal radius 
fracture was associated with a lower frequency of CRPS 
than placebo group, but the difference was not 
statistically significant. Several mechanisms could be 
considered to explain these findings.  
Atkins et al. highlighted that cytokine levels are higher in 
CRPS-affected limbs than in the contra lateral limb or 
control patients.20 The acute phase of CRPS is 
characterized by  classical signs and symptoms of 
inflammation. This suggests that CRPS is an exaggerated 
local inflammatory response to injury.36 Therefore, 
aspirin with its anti-inflammatory effect might help the 
body to overcome this complication.  
CRPS seems to be a local form of the systemic free 
radical disease. In one of the studies of van der Laan et 
al.,37 severely thickened basal membrane layers of the 
capillaries, compatible with overexposure to free 
radicals, have been showed in amputated human 
specimens with CRPS.  
Additionally, van der Laan  et al. reported that in animals, 
induction of free-radical formation in one hind-limb of 
awaked rats mimics the acute signs and symptoms of 
CRPS.38 These findings are supported by the evidence 
from Atkins et al.  that vitamin C is an effective 
prophylaxis against post-traumatic CRPS as a free radical 
scavenger.39 Koseoglus et al. demonstrated that a low-
dose aspirin supplementation (300 mg. daily for 10 days) 
in a short time period significantly increases total 
antioxidant activity.40 Demirci et al.41 also also found that 
in the study of the antioxidant role of aspirin in the serum 
of rats, aspirin improved the relaxation function and 
antioxidant capacity and decreased the oxidant status. 
Therefore, aspirin may play a role in improving the 
general anti-oxidative potency of the blood, so reducing 
the effect of oxygen free radicals in the CRPS process as 
shown in studies conducted by Podhaisky,42 Ristimae et 
al.43 and other studies44,45 
Limitations of our study, i.e. the relatively small study 
population, the recruitement from only one teaching 
hospital and the short follow-up period, do not allow 
generalization of our research findings.  
Positive points of the study are its prospective design and 
strict criteria for patient selection that decrease effects of 
confounding variables. Furthermore, it is the first study 
to evaluate the effects of aspirin in prevention of CRPS, 
not as a treatment. 
In conclusion, although there is no definite successful 
method for prevention or treatment of CRPS to date, this 
study adds substantially to the understanding of this field. 
Administration of aspirin in patients with a distal radius 
fracture was associated with a lower incidence of CRPS, 
though not statistically significant. As with other chronic 
disorders, the future of CRPS prevention and treatment 
may lie in combination therapy. Considering the 
limitations of the present study, further investigations 
needs to be done with a larger sample size, longer follow-
up period and multi-center design. 
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